Entasis Therapeutics Holdings Inc.
ETTXDelisted Jul 11, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001724344
Entasis Therapeutics Holdings Inc. was delisted on Jul 11, 2022; its insiders filed their last Form 4 on Jul 13, 2022; 27 institutions reported holding it in 13F filings for Q2 2022, worth $12.5M in total; no superinvestor held it.
Holders of 5% or more of ETTX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Entasis Therapeutics Holdings Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Entasis Therapeutics Holdings Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
11 Schedule 13D and 13G filings on Entasis Therapeutics Holdings Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jul 11, 20225:27 PM ET | Innoviva, Inc. | 13D/AOld format | – | – | – | SEC |
| May 23, 20228:55 PM ET | Innoviva, Inc. | 13D/AOld format | – | – | – | SEC |
| Mar 15, 20229:00 AM ET | Innoviva, Inc. | 13D/AOld format | – | – | – | SEC |
| Feb 18, 20228:47 PM ET | Innoviva, Inc. | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Eventide Asset Management, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 1, 20226:34 PM ET | Innoviva, Inc. | 13D/AOld format | – | – | – | SEC |
| Jan 18, 2022 | TPG GP A, LLC | 13D/AOld format | – | – | – | SEC |
| Jun 11, 20215:37 PM ET | Innoviva, Inc. | 13D/AOld format | – | – | – | SEC |
| May 3, 20215:19 PM ET | Innoviva, Inc. | 13D/AOld format | – | – | – | SEC |
| Mar 4, 2021 | Sofinnova Venture Partners IX, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Armistice Capital, LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Entasis Therapeutics Holdings Inc. shares.
No Form 144 notices for Entasis Therapeutics Holdings Inc. are on file.